Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for sleep disturbance after acquired brain injury
ACTRN12611000734965Phase 4Completed
- Sponsor
- Monash University
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of melatonin in sleep disorder (2 arms), sponsored by Monash University. Primary endpoints: Sleep onset latency and Sleep quality. Started Mar 2012; status: completed.
02
Drugs
melatonin
03
Conditions
sleep disorder
Beyond the preview
Go deeper on ACTRN12611000734965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000734965.